NASDAQ · Shell Companies · USD

Harvard Ave Acquisition Corporation (HAVA) Stock Analysis

Harvard Ave Acquisition Corporation (HAVA) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

HAVA

$10.21

$0.00 (0.00%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare HAVA with… →

HAVA Key Statistics

As of Sep 4, 2026

Trading

Open: $10.21
Previous Close: $10.21
52-Week Range: 9.87–10.21

Valuation

Market Cap: $211.28M
P/E Ratio: 51.05
EPS (ttm): 0.20

Financials (FY)

Revenue (FY): $0.00
Net Income (FY): $729.12K
Profit margin: 0.00%
Shares Outstanding: 15.86M

Dividend and dates

Avg Volume: 25.93K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

HAVA Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

Year	Return
2026 (partial year)	+2.82%
2025 (partial year)	+0.51%

As of September 4, 2026.

HAVA Valuation vs Shell Companies Median

Median of 587 stocks

Metric	HAVA	Shell Companies median	vs median
P/E	51.05	45.20	13% above
Profit margin	0.00%	0.00%	0.0 pts above

Medians across 587 Shell Companies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

Harvard Ave Acquisition Corporation (HAVA) carries a market capitalisation of $211.28M. It is classified in the Shell Companies industry, within the Financial Services sector.

The most recent close on file for HAVA is $10.21, dated September 4, 2026. The close was unchanged from the previous session. Over the past 52 weeks the price has ranged from $9.87 to $10.21. The latest close sits 3.44% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $0.00. Net income for the same year was $729.12K. Profit margin runs at 0%. Trailing earnings per share are 0.2.

Valuation Assessment

HAVA trades at a trailing price-to-earnings ratio of 51.05. That is 12.94% above the Shell Companies median of 45.2. 587 Shell Companies companies report these metrics, and the medians quoted come from that group.

The stored price history starts on December 15, 2025, and the total return since then is +3.34%.

Growth & Income

No dividend is on file for HAVA.

So far in 2026 the price is +2.82%.

Peer Comparison

Harvard Ave Acquisition Corporation (HAVA) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Harvard Ave Acquisition Corporation	HAVA	$211.28M	51.0
Churchill Capital Corp XI	CCXI	$746.38M	—
Churchill Capital Corp X	CCCX	$711.00M	—
Drugs Made In America Acquisition II Corp.	DMII	$647.83M	35.1

The Shell Companies industry average P/E ratio is 45.2x. Harvard Ave Acquisition Corporation trades at a P/E of 51.0.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Shell Companies Stocks

CCXI

Churchill Capital Corp XI

$746.38M

CCCX

Churchill Capital Corp X

$711.00M

DMII

Drugs Made In America Acquisition II Corp.

$647.83M

BCSS

Bain Capital GSS Investment Corp.

$602.40M

EVAC

EQV Ventures Acquisition Corp. II

$602.01M

CXII

Churchill Capital Corp XII

$594.94M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.08T

JPM

JPMorgan Chase & Co.

$953.33B

Visa Inc.

$700.27B

Mastercard Incorporated

$507.39B

BAC

Bank of America Corporation

$438.31B

View all Financial Services stocks →

About Harvard Ave Acquisition Corporation

Harvard Ave Acquisition Corporation does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Seoul, South Korea.